Results 201 to 210 of about 2,446,428 (296)

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

Molecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urska Ivanus, Carlo Senore, Esther Toes‐Zoutendijk, Carlijn van der Aalst, Carlos Canelo‐Aybar, Fiorella Karina Fernández‐Sáenz, Ariadna Feliu, Hajo Zeeb, Andre L. Carvalho, Erica D'Souza, David Ritchie, Carolina Espina, Iris Lansdorp‐Vogelaar, Andrea DeCensi   +18 more
wiley   +1 more source

Aptamer’s Structure Optimization for Better Diagnosis and Treatment of Glial Tumors [PDF]

Anastasia A. Koshmanova, Polina V. Artyushenko, Irina A. Shchugoreva, Victoriya D. Fedotovskaya, Natalia A. Luzan, Olga S. Kolovskaya, Galina S. Zamay, Kirill A. Lukyanenko, Dmitry B. Veprintsev, Е. Д. Хилажева, Т. N. Zamay, D. A. Ivanova, Maria R. Kastyuk, И. Н. Лапин, В. А. Светличный, Felix N. Tomilin, Nikita A. Shved, Valeriia Gulaia, Vadim Kumeiko, Maxim V. Berezovski, Anna S. Kichkailo   +20 more
openalex   +1 more source

Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes [PDF]

, 2007
Jean Frédéric Boyer, Patricia Balard, Hélène Authier, Bruno Faucon, José Bernad, Bernard Mazières, J. Davignon, Alain Cantagrel, Bernard Pipy, Arnaud Constantin   +9 more
openalex   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Recent advances in bone and soft tissue tumors: lipomatous tumors [PDF]

, 2012
Creytens, David
core   +1 more source

Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration [PDF]

, 2015
Tiziana Triulzi, Loris De Cecco, Marco Sandri, Aleix Prat, Marta Giussani, Biagio Paolini, M.L. Carcangiu, Silvana Canevari, Alberto Bottini, Andrea Balsari, Sylvie Ménard, Daniele Generali, Manuela Campiglio, Serena Di Cosimo, Elda Tagliabue   +14 more
openalex   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Prevalence and mutational determinants of high tumor mutation burden in breast cancer [PDF]

, 2019
Romualdo Barroso‐Sousa, Esha Jain, Ofir Cohen, D. Kim, Jorge E. Buendia-Buendia, Eric P. Winer, Nancy U. Lin, Sara M. Tolaney, Nikhil Wagle   +8 more
openalex   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

Molecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto, Louise Raunkilde, Jan Lindebjerg, Mads Malik Aagaard, Christina Therkildsen, Jakob Kleif, Lars Henrik Jensen, Torben Frøstrup Hansen, Rikke Fredslund Andersen   +8 more
wiley   +1 more source

Clinical Evaluation of M30 and M65 ELISA Cell Death Assays as Circulating Biomarkers in a Drug-Sensitive Tumor, Testicular Cancer

, 2008
De Haas, Alessandra di Pietro, Kathryn Simpson, Coby Meijer, Albert J.H. Suurmeijer, Lee Lancashire, Jeffrey L. Cummings, Steven de Jong, Elisabeth G.E. de Vries, Caroline Dive, Jourik A. Gietema   +10 more
openalex   +1 more source